Antihistamines, leukotriene antagonists, mucolytics and combination cough preparations.
The respiratory and anti-allergic range addresses both chronic and seasonal presentations, from montelukast combinations with levocetirizine, fexofenadine, bilastine and bambuterol through to mucolytic and bronchodilator suspensions formulated separately for adult and paediatric use. Liquid dosage forms dominate this vertical and are produced on dedicated WHO-GMP liquid manufacturing lines, where fill accuracy and flavour-system stability are validated as part of routine batch release.
Our DSIR-approved R&D center continuously executes complex technology transfers and formulation development. If your required therapeutic is not listed in our active commercial matrix, contact our technical team to initiate a custom Contract Manufacturing (CDMO) project.
Submit CDMO / Tech-Transfer Inquiry
